diethyl {2-[(5-chloro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)methyl]benzyl}phosphonate | 1173021-58-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: diethyl {2-[(5-chloro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)methyl]benzyl}phosphonate
• CAS: 1173021-58-3
• 化学式: C₁₆H₂₀ClN₂O₅P
• 分子量: 386.772
• InChiKey: LGVTYJPHZVYRTI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.0
• 重原子数：
  25.0
• 可旋转键数：
  8.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  90.39
• 氢给体数：
  1.0
• 氢受体数：
  6.0

反应信息

• 作为反应物：
  描述：

  diethyl {2-[(5-chloro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)methyl]benzyl}phosphonate 在 三甲基溴硅烷 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 以73.4%的产率得到disodium {2-[(5-chloro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)methyl]benzyl}phosphonate
  参考文献：
  名称：

  在N（1）上具有1- [膦基（甲基/二氟甲基）]-1,2-不饱和部分取代的甲基的5-氯尿嘧啶/胸腺嘧啶的合成和人胸苷磷酸化酶的抑制活性

  摘要：

  Abstractmagnified imageBy attaching (methyl)‐ or (difluoromethyl)‐phosphonate groups to the 1‐positions of ethene, cyclopentene or benzene, and attaching 1‐(methyl)‐5‐chlorouracil or 1‐(methyl)thymine groups to the corresponding 2‐positions, compounds 1–5 were prepared as potential inhibitors of recombinant human thymidine phosphorylase (TP). The products were designed to mimic the interatomic distance (ca. 3.41 Å) between the incoming phosphate and leaving pyrimidine groups at the transition state for the putative SN2 mechanism of TP. Free rotation around the (unsaturated‐CH2)–pyrimidine bonds in 1–5 enabled a span of ca. 2.40–4.40 Å between the CH2 or CF2 C‐atoms in the phosphonates and N(1) of the pyrimidines to be covered. The products were found to be ineffective inhibitors, and some reasons for this are given.

  DOI：

  10.1002/hlca.200900003
• 作为产物：
  描述：

  diethyl {2-[(3-benzoyl-5-chloro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)methyl]benzyl}phosphonate 在 氨 作用下， 以 乙醇 为溶剂， 反应 3.0h， 以0.15 g的产率得到diethyl {2-[(5-chloro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)methyl]benzyl}phosphonate
  参考文献：
  名称：

  在N（1）上具有1- [膦基（甲基/二氟甲基）]-1,2-不饱和部分取代的甲基的5-氯尿嘧啶/胸腺嘧啶的合成和人胸苷磷酸化酶的抑制活性

  摘要：

  Abstractmagnified imageBy attaching (methyl)‐ or (difluoromethyl)‐phosphonate groups to the 1‐positions of ethene, cyclopentene or benzene, and attaching 1‐(methyl)‐5‐chlorouracil or 1‐(methyl)thymine groups to the corresponding 2‐positions, compounds 1–5 were prepared as potential inhibitors of recombinant human thymidine phosphorylase (TP). The products were designed to mimic the interatomic distance (ca. 3.41 Å) between the incoming phosphate and leaving pyrimidine groups at the transition state for the putative SN2 mechanism of TP. Free rotation around the (unsaturated‐CH2)–pyrimidine bonds in 1–5 enabled a span of ca. 2.40–4.40 Å between the CH2 or CF2 C‐atoms in the phosphonates and N(1) of the pyrimidines to be covered. The products were found to be ineffective inhibitors, and some reasons for this are given.

  DOI：

  10.1002/hlca.200900003